MAGELLAN LONGEVITY
HomeResearchStudy library › Does menaquinone-7 (MK-7) supplementation, combined with vitamin D…
Study summary · Nutrition, micronutrients & whole foods

Does menaquinone-7 (MK-7) supplementation, combined with vitamin D, reduce the progression rate of aortic valve calcification (AVC) in men with aortic stenosis?

In one paragraph

Vitamin K2, a randomized trial in 365 men (Circulation 2022, PMID 35465686) — two years of MK-7 and vitamin D supplementation did not slow aortic valve calcification progression in elderly men, despite improving a biomarker of vitamin K status. The rates of heart valve surgery (1 vs 2 patients), all-cause death (1 vs 4 patients), and cardiovascular events (10 vs 10 patients) were also not significantly different.

Source: Circulation 2022, PMID 35465686 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

Circulation · 2022 · PMID 35465686 · DOI 10.1161/CIRCULATIONAHA.121.057008

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Two years of MK-7 and vitamin D supplementation did not slow aortic valve calcification progression in elderly men, despite improving a biomarker of vitamin K status.

The question

Does menaquinone-7 (MK-7) supplementation, combined with vitamin D, reduce the progression rate of aortic valve calcification (AVC) in men with aortic stenosis?

What they tested

Menaquinone-7 (MK-7), a cofactor for carboxylation of proteins inhibiting arterial calcification, may reduce the progression rate of aortic valve calcification (AVC) in patients with aortic stenosis.

How they did it

This was a randomized, double-blind, multicenter trial involving 365 men from the community with an AVC score >300 arbitrary units (AU). Participants were randomized to receive daily treatment with 720 µg MK-7 plus 25 µg vitamin D or a matching placebo for 24 months. The primary outcome was the change in AVC score, with secondary outcomes including changes in aortic valve area, peak aortic jet velocity, heart valve surgery, aortic and coronary artery calcification, and dp-ucMGP levels. Safety outcomes included all-cause death and cardiovascular events.

What they found

The mean increase in AVC score was 275 AU in the intervention group and 292 AU in the placebo group, with a mean difference of 17 AU. There were no significant differences between groups in changes in aortic valve area, peak aortic jet velocity, or progression of aortic and coronary artery calcification. The rates of heart valve surgery (1 vs 2 patients), all-cause death (1 vs 4 patients), and cardiovascular events (10 vs 10 patients) were also not significantly different. However, a significant reduction in dp-ucMGP was observed in the MK-7 plus vitamin D group (-212 pmol/L) compared to the placebo group (45 pmol/L).

Mean Change in AVC Score Over 24 Months
Values shown: Mean Increase in AVC Score (AU)
MK-7 + Vitamin D275
Placebo292

The mean increase in AVC score was 275 AU in the intervention group and 292 AU in the placebo group over 24 months.

What it means

In elderly men with an AVC score >300 AU, 2 years of MK-7 plus vitamin D supplementation did not influence the progression of aortic valve calcification, despite a significant reduction in dp-ucMGP.

Limitations

The study was conducted on elderly men from the community with a specific AVC score, which may limit generalizability to other populations or those with different stages of aortic stenosis.

“a cofactor for the carboxylation of proteins involved in inhibition of arterial calcification”— from the published abstract, Circulation 2022

The paper at a glance

Magellan’s evidence labelmatrix Gla-protein carboxylation (our label for this citation — see PubMed for the paper’s own title and authors)
JournalCirculation
Year2022
PMID35465686 ↗
DOI10.1161/CIRCULATIONAHA.121.057008 ↗
TopicNutrition, micronutrients & whole foods

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Vitamin K2 (MK-7)

In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating dephospho-uncarboxylated MGP by about half and markedly reducing undercarboxylated osteocalcin — and one well-run three-year randomized trial in healthy postmenopausal women found modestly improved arterial…

Vitamin K2 (MK-7)

Vitamin K2 (menaquinone) is a fat-soluble vitamin obtained from fermented foods such as natto and some…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does menaquinone-7 (MK-7) supplementation, combined with vitamin D, reduce the progression rate of aortic valve calcification (AVC) in men with aortic stenosis? [Plain-English summary of Circulation 2022, PMID 35465686, DOI 10.1161/CIRCULATIONAHA.121.057008]. Magellan Longevity. https://magellanlongevity.com/study/s138.html
BibTeX
@misc{magellan_s138, title = {Does menaquinone-7 (MK-7) supplementation, combined with vitamin D, reduce the progression rate of aortic valve calcification (AVC) in men with aortic stenosis?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/s138.html}}, note = {Plain-English summary of PubMed PMID 35465686; DOI 10.1161/CIRCULATIONAHA.121.057008; Circulation 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/s138.html

Related studies in the Magellan library

All 7 Magellan summaries on nutrition, micronutrients & whole foods →

How this summary was made. Every section above restates what the published abstract of PMID 35465686 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.